The age of the
mind-machine
is here.
The future of consciousness, tracked daily.
Neurotechnology is rewriting what it means to be human — and what it means to be intelligent. We track the companies, breakthroughs, and ideas at this frontier, so you don't miss a moment of the most important shift in the history of mind.
622+
Companies tracked
across 9 categories
$18B+
VC invested
in the field globally
90+
Articles published
research & industry
Every Sunday
Weekly digest
NeuroTech Digest
"The question is no longer whether machines can think —
but whether they can learn to love."
Browse by category
View all 622 companies →Featured companies
COMPASS Pathways
Psychedelics
COMPASS Pathways is a mental health care company focused on accelerating patient access to psilocybin therapy, with their proprietary COMP360 psilocybin formulation in Phase 3 trials for treatment-resistant depression. They are one of the most advanced and well-funded psychedelic medicine companies globally.
Kernel
Research Tools
Kernel builds non-invasive neuroimaging helmets — the Flow (TD-fNIRS) and Flux (MEG) systems — designed to make high-resolution brain scanning accessible outside of hospital settings. Founded by Bryan Johnson, the company aims to democratize neuroscience research and brain measurement at scale.
MindMed
Psychedelics
MindMed is a clinical-stage psychedelic medicine company developing novel therapeutics derived from LSD, MDMA, and ibogaine analogs for neurological and psychiatric disorders. Their lead asset MM120 (LSD tartrate) has shown promising Phase 2b results for generalized anxiety disorder.
Recently added
Funding spotlight
CognWave Health
Seed — $4.5M
Limbic Neuromodulation
Series A — $22M
Neurode Inc.
Seed — $6M
Neuroelectronics Research Flanders
Public Research Funding
Cortical.io
Series A
Helius Medical Technologies
Publicly Traded (NASDAQ: HSDT)
Latest news
FDA clears Modius Spero via De Novo pathway, marking a significant regulatory milestone for neuromodulation-based PTSD treatment.
BRYM has secured €650K in early-stage funding to develop a wearable neurofeedback platform targeting both consumer wellness and clinical applications.
European neurotech startup ReVision Implant has closed a €4 million funding round to develop its visual cortex implant technology.
Catalio-backed neuroscience startup Flourish has launched publicly with investment from Bezos Expeditions and Google Ventures.
Science Corp. has launched its Prima vision-restoring BCI implant in Europe, marking a significant commercial milestone for photovoltaic retinal technology.
Able-bodied individuals have received brain-computer interface implants for the first time, marking a major shift in BCI trial eligibility criteria.
A new roadmap outlines how closed-loop brain-computer interfaces could transform clinical care for depression, anxiety, and PTSD.
A closer look at the neurotech companies turning cognition — long the most private, hardest-to-measure part of a person — into something you can actually track over time.
Every Sunday
The NeuroTech Digest
Funding rounds, breakthroughs, and top jobs — curated weekly for industry professionals.
Subscribe free →For companies
Reach neurotech decision-makers
Premium listings, newsletter sponsorships, and featured placements.
View packages →News & insights
All articles →FDA Grants De Novo Approval to Modius Spero Neuromodulation Device for PTSD
FDA clears Modius Spero via De Novo pathway, marking a significant regulatory milestone for neuromodulation-based PTSD treatment.
2026-07-27
BRYM Raises €650K to Build Wearable Neurofeedback Platform for Consumer and Clinical Markets
BRYM has secured €650K in early-stage funding to develop a wearable neurofeedback platform targeting both consumer wellness and clinical applications.
2026-07-26
ReVision Implant Secures €4 Million to Advance Next-Generation Visual Neuroprosthetics
European neurotech startup ReVision Implant has closed a €4 million funding round to develop its visual cortex implant technology.
2026-07-25
Flourish Emerges from Stealth with Bezos and Google Ventures Backing to Advance Neuroscience Therapeutics
Catalio-backed neuroscience startup Flourish has launched publicly with investment from Bezos Expeditions and Google Ventures.
2026-07-24
Science Corp. Launches Prima BCI Implant in Europe, Bringing Vision Restoration to a New Market
Science Corp. has launched its Prima vision-restoring BCI implant in Europe, marking a significant commercial milestone for photovoltaic retinal technology.
2026-07-23
First Able-Bodied Individuals Receive Brain-Computer Implants in Landmark Expansion of BCI Eligibility
Able-bodied individuals have received brain-computer interface implants for the first time, marking a major shift in BCI trial eligibility criteria.
2026-07-22
The field, by the numbers
622+
Companies mapped
across 9 sectors
$18B+
VC invested
in the field globally
3×/week
News published
Mon · Wed · Fri
30+
Articles
research & industry
Companies by sector
23
Brain-Computer
11
Cognitive
39
Mental
35
Neuromodulation
31
Neuropharmaceuticals
20
Neurodiagnostics
12
Research
13
Neurofeedback
40
Psychedelics
The NeuroTech Digest
The signal through the noise — breakthroughs, funding, and ideas at the edge of mind and machine. Curated weekly.
No spam. Unsubscribe anytime.